U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07318155) titled 'A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease' on Dec. 07, 2025.
Brief Summary: The study is a Phase 2a, randomized, double-blind, placebo-controlled, sequential cohort study to evaluate the pharmacodynamics (PD), safety and pharmacokinetics (PK) of multiple doses of SRSD107 in participants with coronary arterial disease (CAD) and/or peripheral arterial disease (PAD) with aspirin as background concomitant therapy.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Coronary Artery Disease (CAD)
Peripheral Arterial Disease
Intervention:
DRUG: SRSD107
Administered S.C....